These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20443087)

  • 1. Gliclazide microcrystals prepared by two methods of in situ micronization: pharmacokinetic studies in diabetic and normal rats.
    Talari R; Varshosaz J; Mostafavi SA; Nokhodchi A
    AAPS PharmSciTech; 2010 Jun; 11(2):786-92. PubMed ID: 20443087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution enhancement of gliclazide using pH change approach in presence of twelve stabilizers with various physico-chemical properties.
    Talari R; Varshosaz J; Mostafavi SA; Nokhodchi A
    J Pharm Pharm Sci; 2009; 12(3):250-65. PubMed ID: 20067702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
    Devarajan PV; Sonavane GS
    Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats.
    Al-Salami H; Butt G; Tucker I; Golocorbin-Kon S; Mikov M
    Eur J Drug Metab Pharmacokinet; 2012 Jun; 37(2):99-108. PubMed ID: 21874525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.
    Nazief AM; Hassaan PS; Khalifa HM; Sokar MS; El-Kamel AH
    Int J Nanomedicine; 2020; 15():1129-1148. PubMed ID: 32110012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000.
    Asyarie S; Rachmawati H
    PDA J Pharm Sci Technol; 2007; 61(5):400-10. PubMed ID: 18047178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats.
    Al-Salami H; Butt G; Fawcett JP; Tucker IG; Golocorbin-Kon S; Mikov M
    Eur J Drug Metab Pharmacokinet; 2008; 33(2):101-6. PubMed ID: 18777945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes.
    Mikov M; Al-Salami H; Golocorbin-Kon S; Skrbic R; Raskovic A; Fawcett JP
    Eur J Drug Metab Pharmacokinet; 2008; 33(3):137-42. PubMed ID: 19007038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation, Pharmacokinetics evaluation, and IVIVC Assessment of Gliclazide Multiparticulates in Rat Model.
    El-Ashmawy AA; Abdou AR; Taha NF; Elsayed EW; Mahmoud KM; Emara LH
    AAPS PharmSciTech; 2021 Apr; 22(4):146. PubMed ID: 33929614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
    Al-Kassas RS; Al-Gohary OM; Al-Faadhel MM
    Int J Pharm; 2007 Aug; 341(1-2):230-7. PubMed ID: 17507189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect.
    Golocorbin-Kon S; Calasan J; Milijasevic B; Vukmirovic S; Lalic-Popovic M; Mikov M; Al-Salami H
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):1005-1011. PubMed ID: 28547295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication of Second Generation Smarter PLGA Based Nanocrystal Carriers for Improvement of Drug Delivery and Therapeutic Efficacy of Gliclazide in Type-2 Diabetes Rat Model.
    Panda BP; Krishnamoorthy R; Bhattamisra SK; Shivashekaregowda NKH; Seng LB; Patnaik S
    Sci Rep; 2019 Nov; 9(1):17331. PubMed ID: 31758056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide.
    Hong SS; Lee SH; Lee YJ; Chung SJ; Lee MH; Shim CK
    J Control Release; 1998 Feb; 51(2-3):185-92. PubMed ID: 9685916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality by Design Approach for Developing Lipid-Based Nanoformulations of Gliclazide to Improve Oral Bioavailability and Anti-Diabetic Activity.
    Patel P; Pailla SR; Rangaraj N; Cheruvu HS; Dodoala S; Sampathi S
    AAPS PharmSciTech; 2019 Jan; 20(2):45. PubMed ID: 30617566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of anti-diabetic drug Gliclazide from poly(caprolactone)/poly(acrylic acid) hydrogels.
    Bajpai SK; Chand N; Soni S
    J Biomater Sci Polym Ed; 2015; 26(14):947-62. PubMed ID: 26135033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete bioavailability and lack of food-effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers.
    Delrat P; Paraire M; Jochemsen R
    Biopharm Drug Dispos; 2002 May; 23(4):151-7. PubMed ID: 12015789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying the Taguchi design for optimized formulation of sustained release gliclazide chitosan beads: an in vitro/in vivo study.
    Varshosaz J; Tavakoli N; Minayian M; Rahdari N
    AAPS PharmSciTech; 2009; 10(1):158-65. PubMed ID: 19205888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swelling behavior of cross-linked dextran hydrogels and preliminary Gliclazide release behavior.
    Bajpai SK; Chand N; Tiwari S; Soni S
    Int J Biol Macromol; 2016 Dec; 93(Pt A):978-987. PubMed ID: 27664925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 18alpha-glycyrrhizin on the pharmacodynamics and pharmacokinetics of glibenclamide in alloxan-induced diabetic rats.
    Ao Y; Chen J; Yue J; Peng RX
    Eur J Pharmacol; 2008 Jun; 587(1-3):330-5. PubMed ID: 18462715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations and hypoglycemic effect of gliclazide: crosspovidone solid dispersion on streptozotocin induced diabetic rats.
    Adibkia K; Babaei H; Asnaashari S; Andalib S; Khorrami A; Ghavimi H; Jadidinia V; Hajiloo H; Barzegar-Jalali M
    Drug Res (Stuttg); 2013 Feb; 63(2):94-7. PubMed ID: 23427050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.